Superworth

Vertex Pharmaceuticals market cap VRTX

Share price times shares outstanding: what the whole company sells for, since 2010.

Today, Nov 3, 2026
$137.1B
Highest close in our data
$141.7B
Oct 2026

Vertex Pharmaceuticals is worth $137.1B at the close on Nov 3, 2026, at $543.68 a share.

That is up 32% over the last year and up 180% over five years.

Its highest close in our data was $141.7B in Oct 2026.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$140.2B$107.7B$141.7B+19%
2025$117.4B$94B$129.6B+12%
2024$105.3B$101.8B$133.1B+0%
2023$104.8B$73.8B$105.8B+41%
2022$74.1B$56.4B$82.5B+33%
2021$55.8B$46.4B$61.8B−9%
2020$61.5B$53.4B$76.4B+8%
2019$56.8B$42.6B$57.4B+38%
2018$41.3B$38.1B$49.3B+9%
2017$37.9B$19.7B$40.9B+107%
2016$18.3B$18.3B$27.2B−41%
2015$30.9B$25.3B$33.7B+9%
2014$28.5B$14.9B$28.6B+66%
2013$17.2B$9.9B$19.6B+93%
2012$8.9B$7.1B$13.7B+28%
2011$6.9B$5.5B$11.8B−3%
2010$7.1B$6.5B$7.8Bn/a

Against its peers

Companies in Biotechnology nearest Vertex Pharmaceuticals' size, closest first, today.

CompanyMarket cap
VRTXVertex Pharmaceuticals$137.1B
REGNRegeneron Pharmaceuticals$100B
ONCBeOne Medicines$40.2B
UTHRUnited Therapeutics$25.9B
INCYIncyte$24.3B
ALNYAlnylam Pharmaceuticals$21.2B
EXELExelixis$17.4B
NBIXNeurocrine Biosciences$14.8B
HALOHalozyme Therapeutics$14.6B
Peer median$22.8B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Vertex Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.